Taxanes Hybrid Nanovectors: From Design to Physico‐Chemical Evaluation of Docetaxel and Paclitaxel Gold (III)‐PEGylated Complex Nanocarriers
Source abstract
Abstract
Abstract This study gives an original methodology to synthetize novel metallo‐drugs nanoparticles relevant for medicinal chemistry. Gold (HAuCl4) are complexes with antitumor compounds (paclitaxel (PTX); docetaxel (DTX)) and dicarboxylic acid‐terminated polyethylene‐glycol (PEG) that plays a role of surfactants. The proposed synthesis is fast and leads to hybrid‐metal nanoparticles (AuNPs) in which drug solubility is improved. The interactions between drugs (DTX, PTX), PEG diacid (PEG), and Au (III) ions to form hybrid nanocarriers called DTX IN PEG‐AuNPs and PTX IN PEG‐AuNPs, are characterized by various analytical techniques (Raman and UV–vis spectroscopies) and transmission electron microscopy. The efficient drugs release under pH conditions is also achieved and characterized showing an amazing reversible equilibrium between Au (III)‐complex‐drug and Au0NPs. For therapeutic purposes, such AuNPs are then decorated with the anti‐EGFR polyclonal antibodies, which specifically recognizes the hERG1 channel aberrantly expressed on the membrane of human lung cancer cells. This paper, through an original chemical approach, will occupy an important position in the field of nanomedicine, and hope that novel perspectives will be proposed for the development of high drug‐loading nanomedicines.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CNRS UMR 7244 CSPBAT Laboratoire de Chimie Structures et Propriétés de Biomateriaux et d'Agents Therapeutiques Université Paris 13 Sorbonne Paris Cité 93200 Bobigny France
Southwest Hospital Third Military Medical University Chongqing 400038 China
References (55)
Show source-provided references
1. 10.1016/j.msec.2017.03.28210.1016/j.msec.2017.03.282 ↗
2. Carabineiro S. A. C. · Molecules · 2017 · 22
3. 10.1517/1742524100377701010.1517/17425241003777010 ↗
4. 10.1073/pnas.100702610710.1073/pnas.1007026107 ↗
5. 10.2147/IJN.S9747610.2147/IJN.S97476 ↗
6. 10.1016/j.cis.2004.06.00110.1016/j.cis.2004.06.001 ↗
7. 10.1016/S1470-2045(05)70094-210.1016/S1470-2045(05)70094-2 ↗
8. 10.1023/A:101068291680810.1023/A:1010682916808 ↗
9. 10.1517/17425247.2012.69660610.1517/17425247.2012.696606 ↗
10. 10.1038/sj.bjc.660275010.1038/sj.bjc.6602750 ↗
11. 10.1259/bjr/5944883310.1259/bjr/59448833 ↗
12. 10.1039/b806051g10.1039/b806051g ↗
13. 10.1002/cmdc.20110031110.1002/cmdc.201100311 ↗
14. 10.1007/978-1-60761-609-2_2510.1007/978-1-60761-609-2_25 ↗
15. 10.1021/ja075181k10.1021/ja075181k ↗
16. 10.1016/j.biomaterials.2009.07.04810.1016/j.biomaterials.2009.07.048 ↗
17. 10.1016/j.biomaterials.2009.07.02010.1016/j.biomaterials.2009.07.020 ↗
18. 10.1016/j.nano.2011.06.00510.1016/j.nano.2011.06.005 ↗
19. 10.2147/IJN.S4692110.2147/IJN.S46921 ↗
20. 10.1021/acsami.6b0725010.1021/acsami.6b07250 ↗
21. 10.1016/S0162-0134(97)00030-510.1016/S0162-0134(97)00030-5 ↗
22. Ramaswamy H. N. · 1995 · 105
23. 10.2147/IJN.S13278010.2147/IJN.S132780 ↗
24. Taylor J. W. · Angew. Chem., Int. Ed. Engl. · 2017
25. 10.1039/C4RA15743E10.1039/C4RA15743E ↗
26. 10.1088/0957-4484/27/19/19570110.1088/0957-4484/27/19/195701 ↗
27. 10.1002/anie.20140356710.1002/anie.201403567 ↗
28. 10.2165/00003088-199936020-0000210.2165/00003088-199936020-00002 ↗
29. 10.1021/acs.bioconjchem.6b0040510.1021/acs.bioconjchem.6b00405 ↗
30. 10.1002/tcr.100810.1002/tcr.1008 ↗
31. 10.1021/jp991764810.1021/jp9917648 ↗
32. Devi T. S. R. · Int. J. Pharm. Sci. Rev. Res. · 2010 · 2 · 106
33. 10.1016/j.saa.2004.11.01410.1016/j.saa.2004.11.014 ↗
34. 10.1039/c3an00787a10.1039/c3an00787a ↗
35. 10.1021/ac061218s10.1021/ac061218s ↗
36. G.Socrate Wiley New York February2004 p.366.
37. 10.1016/j.jconrel.2007.05.00710.1016/j.jconrel.2007.05.007 ↗
38. 10.1038/srep3280810.1038/srep32808 ↗
39. 10.1016/j.colsurfa.2006.12.05110.1016/j.colsurfa.2006.12.051 ↗
40. a)M.Khafaji M.Vossoughi M. R.Hormozi‐Nezhad R.Dinarvand F.Börrnert A.Irajizad 2016 6 27847;10.1038/srep27847 ↗
41. 10.1016/j.cplett.2015.08.03810.1016/j.cplett.2015.08.038 ↗
42. 10.1007/s11671-009-9453-010.1007/s11671-009-9453-0 ↗
43. 10.1021/ja046567n10.1021/ja046567n ↗
44. 10.1021/bm050196110.1021/bm0501961 ↗
45. Liu C.‐J. · Nanoscale Res. Lett. · 2010 · 5 · 12410.1007/s11671-009-9453-0 ↗
46. 10.1007/s11671-009-9453-010.1007/s11671-009-9453-0 ↗
47. 10.1186/1556-276X-6-44010.1186/1556-276X-6-440 ↗
48. 10.1002/ddr.2026810.1002/ddr.20268 ↗
49. Chan B. A. · Transl. Lung Cancer Res. · 2015 · 4 · 36
50. 10.1056/NEJMra070770410.1056/NEJMra0707704 ↗
51. 10.1677/erc.0.010000110.1677/erc.0.0100001 ↗
52. 10.1038/sj.onc.120408210.1038/sj.onc.1204082 ↗
53. 10.1038/srep1704010.1038/srep17040 ↗
54. 10.1016/j.sbsr.2016.04.00210.1016/j.sbsr.2016.04.002 ↗
55. 10.1016/j.biomaterials.2013.10.04110.1016/j.biomaterials.2013.10.041 ↗